Literature DB >> 33262293

Unlike LGR4, LGR5 potentiates Wnt-β-catenin signaling without sequestering E3 ligases.

Soohyun Park1, Ling Wu1, Jianghua Tu1, Wangsheng Yu1, Yukimatsu Toh1, Kendra S Carmon1, Qingyun J Liu2.   

Abstract

LGR4 and LGR5 encode two homologous receptors with critical, yet distinct, roles in organ development and adult stem cell survival. Both receptors are coexpressed in intestinal crypt stem cells, bind to R-spondins (RSPOs) with high affinity, and potentiate Wnt-β-catenin signaling, presumably by the same mechanism: forming RSPO-bridged complexes with the E3 ligases RNF43 and ZNRF3 to inhibit ubiquitylation of Wnt receptors. However, direct evidence for RSPO-bound, full-length LGR5 interacting with these E3 ligases in whole cells has not been reported, and only LGR4 is essential for the self-renewal of intestinal stem cells. Here, we examined the mechanisms of action of LGR4 and LGR5 in parallel using coimmunoprecipitation, proximity ligation, competition binding, and time-resolved FRET assays in whole cells. Full-length LGR4 formed a tight complex with ZNRF3 and RNF43 even without RSPO, whereas LGR5 did not interact with either E3 ligase with or without RSPO. Domain-swapping experiments with LGR4 and LGR5 revealed that the seven-transmembrane domain of LGR4 conferred interaction with the E3 ligases. Native LGR4 and LGR5 existed as dimers on the cell surface, and LGR5 interacted with both FZD and LRP6 of the Wnt signalosome to enhance LRP6 phosphorylation and potentiate Wnt-β-catenin signaling. These findings provide a molecular basis for the weaker activity of LGR5 in the potentiation of Wnt signaling that may underlie the distinct roles of LGR4 and LGR5 in organ development, as well as the self-renewal and fitness of adult stem cells.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2020        PMID: 33262293     DOI: 10.1126/scisignal.aaz4051

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  5 in total

1.  Drug Conjugates of Antagonistic R-Spondin 4 Mutant for Simultaneous Targeting of Leucine-Rich Repeat-Containing G Protein-Coupled Receptors 4/5/6 for Cancer Treatment.

Authors:  Jie Cui; Yukimatsu Toh; Soohyun Park; Wangsheng Yu; Jianghua Tu; Ling Wu; Li Li; Joan Jacob; Sheng Pan; Kendra S Carmon; Qingyun J Liu
Journal:  J Med Chem       Date:  2021-08-18       Impact factor: 8.039

Review 2.  LGR4, a G Protein-Coupled Receptor With a Systemic Role: From Development to Metabolic Regulation.

Authors:  Joanna Filipowska; Nagesha G Kondegowda; Nancy Leon-Rivera; Sangeeta Dhawan; Rupangi C Vasavada
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

Review 3.  Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis.

Authors:  Linlin Yang; Jing Wang; Xiaodi Gong; Qiong Fan; Xiaoming Yang; Yunxia Cui; Xiaoyan Gao; Lijuan Li; Xiao Sun; Yuhong Li; Yudong Wang
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.599

Review 4.  Intestinal Wnt in the transition from physiology to oncology.

Authors:  Julia Swoboda; Patrick Mittelsdorf; Yuan Chen; Ralf Weiskirchen; Johannes Stallhofer; Silke Schüle; Nikolaus Gassler
Journal:  World J Clin Oncol       Date:  2022-03-24

5.  A Wnt-Independent LGR4-EGFR Signaling Axis in Cancer Metastasis.

Authors:  Fei Yue; Weiyu Jiang; Amy T Ku; Adelaide I J Young; Weijie Zhang; Eric P Souto; Yankun Gao; Zihan Yu; Yi Wang; Chad J Creighton; Chandandeep Nagi; Tao Wang; Susan G Hilsenbeck; Xin-Hua Feng; Shixia Huang; Cristian Coarfa; Xiang H-F Zhang; Qingyun Liu; Xia Lin; Yi Li
Journal:  Cancer Res       Date:  2021-06-07       Impact factor: 13.312

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.